CSPC Pharmaceutical-UnspoadrCSPCY
13F holders, Q1 2024 (March 31)3holders
$3.11avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding CSPC Pharmaceutical-Unspoadr (CSPCY) in their 13F filings. The largest holders were Rhumbline Advisers ($81K), Operose Advisors LLC ($6K) and PNC Financial Services Group, Inc. ($647).
- Company
- CSPC Pharmaceutical-Unspoadr
- Filed as
- 1SPC PHARM ADR (Q1 2024)
- CUSIP
- 12591J207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| Rhumbline Advisers | 0.00% | No change | 26,068 | $81K |
| Operose Advisors LLC | 0.00% | No change | 2,030 | $6K |
| PNC Financial Services Group, Inc. | 0.00% | Add +8.9% | 208 | $647 |
"% of holder's portfolio" is CSPCY's weight in each manager's 13F, not the share of CSPC Pharmaceutical-Unspoadr the manager owns.